Why people choose to not use complementary therapies during cancer treatment: A focus group study

Lisa Beatty, B Koczwara, Vikki Knott, T Wade

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

While 50% of cancer patients use complementary therapies (CT) during treatment, few studies have examined why individuals choose not to use CT. This study aimed to address this gap in knowledge using a focus group methodology, where 36 participants took part in one of eight groups; participants were recruited until saturation of themes was achieved. Three categories of participants were investigated: patients/recent survivors (n = 14); volunteers/advocates (n = 16), the majority of whom were also long-term survivors; and health professionals (n = 6). Focus groups were digitally audio-recorded, transcribed, and coded thematically using NVivo software. Reasons for non-use fell into four broad themes: (1) Resource barriers, particularly the cost and lack of time; (2) fear and distrust, including the potential for drug interactions; (3) lack of evidence, including the unproven nature of many CT practices; and (4) satisfaction with conventional treatment. Two further themes related to the benefits of non-use and reasons for discontinuation. A sub-analysis indicated that reasons for non-use differed by CT category, with non-use being mentioned more frequently for biologically based and body-based therapies. Differences in understanding CT non-use emerged between patients, volunteers and health professionals. Findings have clinical implications regarding tailoring information for patients during and after cancer
Original languageEnglish
Pages (from-to)98-106
Number of pages9
JournalEuropean Journal of Cancer Care
Volume21
Issue number1
DOIs
Publication statusPublished - 2011

Fingerprint

Complementary Therapies
Focus Groups
Neoplasms
Survivors
Volunteers
Therapeutics
Health
Drug Interactions
Fear
Software
Costs and Cost Analysis

Cite this

Beatty, Lisa ; Koczwara, B ; Knott, Vikki ; Wade, T. / Why people choose to not use complementary therapies during cancer treatment: A focus group study. In: European Journal of Cancer Care. 2011 ; Vol. 21, No. 1. pp. 98-106.
@article{66a4458a858e4edab7dd14fcadbf9727,
title = "Why people choose to not use complementary therapies during cancer treatment: A focus group study",
abstract = "While 50{\%} of cancer patients use complementary therapies (CT) during treatment, few studies have examined why individuals choose not to use CT. This study aimed to address this gap in knowledge using a focus group methodology, where 36 participants took part in one of eight groups; participants were recruited until saturation of themes was achieved. Three categories of participants were investigated: patients/recent survivors (n = 14); volunteers/advocates (n = 16), the majority of whom were also long-term survivors; and health professionals (n = 6). Focus groups were digitally audio-recorded, transcribed, and coded thematically using NVivo software. Reasons for non-use fell into four broad themes: (1) Resource barriers, particularly the cost and lack of time; (2) fear and distrust, including the potential for drug interactions; (3) lack of evidence, including the unproven nature of many CT practices; and (4) satisfaction with conventional treatment. Two further themes related to the benefits of non-use and reasons for discontinuation. A sub-analysis indicated that reasons for non-use differed by CT category, with non-use being mentioned more frequently for biologically based and body-based therapies. Differences in understanding CT non-use emerged between patients, volunteers and health professionals. Findings have clinical implications regarding tailoring information for patients during and after cancer",
keywords = "Benefits, Cancer, Complementary therapies, Decision making, Motivators, Patients",
author = "Lisa Beatty and B Koczwara and Vikki Knott and T Wade",
year = "2011",
doi = "10.1111/J.1365-2354.2011.01279.X",
language = "English",
volume = "21",
pages = "98--106",
journal = "European Journal of Cancer Care (Online)",
issn = "0961-5423",
publisher = "Wiley-Blackwell",
number = "1",

}

Why people choose to not use complementary therapies during cancer treatment: A focus group study. / Beatty, Lisa; Koczwara, B; Knott, Vikki; Wade, T.

In: European Journal of Cancer Care, Vol. 21, No. 1, 2011, p. 98-106.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Why people choose to not use complementary therapies during cancer treatment: A focus group study

AU - Beatty, Lisa

AU - Koczwara, B

AU - Knott, Vikki

AU - Wade, T

PY - 2011

Y1 - 2011

N2 - While 50% of cancer patients use complementary therapies (CT) during treatment, few studies have examined why individuals choose not to use CT. This study aimed to address this gap in knowledge using a focus group methodology, where 36 participants took part in one of eight groups; participants were recruited until saturation of themes was achieved. Three categories of participants were investigated: patients/recent survivors (n = 14); volunteers/advocates (n = 16), the majority of whom were also long-term survivors; and health professionals (n = 6). Focus groups were digitally audio-recorded, transcribed, and coded thematically using NVivo software. Reasons for non-use fell into four broad themes: (1) Resource barriers, particularly the cost and lack of time; (2) fear and distrust, including the potential for drug interactions; (3) lack of evidence, including the unproven nature of many CT practices; and (4) satisfaction with conventional treatment. Two further themes related to the benefits of non-use and reasons for discontinuation. A sub-analysis indicated that reasons for non-use differed by CT category, with non-use being mentioned more frequently for biologically based and body-based therapies. Differences in understanding CT non-use emerged between patients, volunteers and health professionals. Findings have clinical implications regarding tailoring information for patients during and after cancer

AB - While 50% of cancer patients use complementary therapies (CT) during treatment, few studies have examined why individuals choose not to use CT. This study aimed to address this gap in knowledge using a focus group methodology, where 36 participants took part in one of eight groups; participants were recruited until saturation of themes was achieved. Three categories of participants were investigated: patients/recent survivors (n = 14); volunteers/advocates (n = 16), the majority of whom were also long-term survivors; and health professionals (n = 6). Focus groups were digitally audio-recorded, transcribed, and coded thematically using NVivo software. Reasons for non-use fell into four broad themes: (1) Resource barriers, particularly the cost and lack of time; (2) fear and distrust, including the potential for drug interactions; (3) lack of evidence, including the unproven nature of many CT practices; and (4) satisfaction with conventional treatment. Two further themes related to the benefits of non-use and reasons for discontinuation. A sub-analysis indicated that reasons for non-use differed by CT category, with non-use being mentioned more frequently for biologically based and body-based therapies. Differences in understanding CT non-use emerged between patients, volunteers and health professionals. Findings have clinical implications regarding tailoring information for patients during and after cancer

KW - Benefits

KW - Cancer

KW - Complementary therapies

KW - Decision making

KW - Motivators

KW - Patients

U2 - 10.1111/J.1365-2354.2011.01279.X

DO - 10.1111/J.1365-2354.2011.01279.X

M3 - Article

VL - 21

SP - 98

EP - 106

JO - European Journal of Cancer Care (Online)

JF - European Journal of Cancer Care (Online)

SN - 0961-5423

IS - 1

ER -